-
NUMBER OF INSIDER BUYING
(Last 12 Months)
3 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$22.20 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$22.47 M
Olema Pharmaceuticals, Inc. Insider Transactions
Olema Pharmaceuticals, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Harmon Cyrus
Director |
Sell | 5,000 @ $12.26 | $61,300 | 756,283 | 07/11/2024 | 07/12/2024 | |
Harmon Cyrus
Director |
Sell | 20,000 @ $10.77 | $215,400 | 761,283 | 06/28/2024 | 07/02/2024 | |
Graham G. Walmsley
Director |
Sell | 475,000 @ $14.85 | $7.05 M | 708,114 | 06/04/2024 | 06/06/2024 | |
Graham G. Walmsley
Director |
Sell | 700,000 @ $14.85 | $10.40 M | 700,761 | 06/04/2024 | 06/06/2024 | |
Harmon Cyrus
Director |
Sell | 5,000 @ $12.33 | $61,650 | 781,283 | 06/04/2024 | 06/04/2024 | |
Harmon Cyrus
Director |
Sell | 5,000 @ $10.93 | $54,650 | 786,283 | 06/03/2024 | 06/04/2024 | |
Harmon Cyrus
Director |
Sell | 15,000 @ $9.41 | $141,150 | 791,283 | 05/31/2024 | 06/04/2024 | |
Harmon Cyrus
Director |
Sell | 5,000 @ $10.92 | $54,600 | 806,283 | 05/06/2024 | 05/07/2024 | |
Harmon Cyrus
Director |
Sell | 15,000 @ $9.51 | $142,650 | 811,283 | 04/30/2024 | 05/02/2024 | |
Harmon Cyrus
Director |
Sell | 20,000 @ $10.97 | $219,400 | 826,283 | 03/28/2024 | 03/29/2024 | |
Harmon Cyrus
Director |
Sell | 24,900 @ $12.41 | $309,009 | 846,383 | 02/29/2024 | 03/04/2024 | |
Harmon Cyrus
Director |
Sell | 100 @ $13.00 | $1,300 | 846,283 | 02/29/2024 | 03/04/2024 | |
Harmon Cyrus
Director |
Sell | 5,000 @ $15.56 | $77,800 | 871,283 | 02/01/2024 | 02/02/2024 | |
Harmon Cyrus
Director |
Sell | 25,000 @ $12.23 | $305,750 | 876,283 | 01/31/2024 | 02/02/2024 | |
Harmon Cyrus
Director |
Sell | 22,500 @ $13.30 | $299,250 | 903,783 | 12/29/2023 | 01/02/2024 | |
Harmon Cyrus
Director |
Sell | 2,500 @ $14.10 | $35,250 | 901,283 | 12/29/2023 | 01/02/2024 | |
Paradigm Biocapital Advisors LP
10 percent owner |
Buy | 100,000 @ $11.60 | $1.16 M | 6,590,981 | 12/06/2023 | 12/08/2023 | |
Graham G. Walmsley
Director |
Buy | 50,000 @ $14.95 | $747,480 | 1,750,000 | 12/05/2023 | 12/18/2023 | |
Graham G. Walmsley
Director |
Buy | 31,870 @ $14.73 | $469,550 | 1,700,000 | 12/05/2023 | 12/18/2023 | |
Harmon Cyrus
Director |
Sell | 25,000 @ $12.57 | $314,250 | 926,283 | 11/30/2023 | 12/01/2023 |
Olema Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Olema Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Olema Pharmaceuticals, Inc. includes BVF PARTNERS L P/IL, Graham G. Walmsley, Myles David C., Harmon Cyrus, Kovacs Shane William Charles, Bohen Sean, Zojwalla Naseem, Paradigm Biocapital Advisors LP.
-
How much insider selling is happening at Olema Pharmaceuticals, Inc.?
Insiders have sold a total of 1.57 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 22.47 M sold.
-
Which Olema Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Olema Pharmaceuticals, Inc. shares in the last 12 months: Myles David C. ($613,961), Harmon Cyrus ($3.10 M), Kovacs Shane William Charles ($269,656), Bohen Sean ($824,134), Zojwalla Naseem ($209,296), Graham G. Walmsley ($17.45 M),
-
How much insider buying is happening at Olema Pharmaceuticals, Inc.?
Insiders have purchased a total of 2.20 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 22.20 M sold.
-
Which Olema Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased Olema Pharmaceuticals, Inc. shares in the last 12 months: BVF PARTNERS L P/IL ($14.82 M), Graham G. Walmsley ($6.22 M), Paradigm Biocapital Advisors LP ($1.16 M),